Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • Log out
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Molecular Biology and Genetics

Tissue-specific Induction of p53 Targets in Vivo

Peiwen Fei, Eric J. Bernhard and Wafik S. El-Deiry
Peiwen Fei
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric J. Bernhard
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wafik S. El-Deiry
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published December 2002
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

The in vivo response to radiotherapy is not well understood but appears to involve the p53 tumor suppressor protein. We investigated the expression of apoptosis-inducing p53 target genes during γ-irradiation-induced cell death in p53+/+ or p53−/− mouse tissues using in situ hybridization. Our results reveal striking tissue specificity with distinct regulation of target p53-induced genes in different cells and tissue compartments, as well as variations in dependence on p53 for basal expression. p53-dependent induction of Puma occurred in the splenic white pulp, whereas Noxa and Bid were induced in the red pulp. These patterns correlated with activation of caspase-3 in both compartments. All apoptotic targets of p53 studied here (DR5, Bid, Puma, Noxa) were induced in the jejunum and ileum, which appeared to be the tissues most sensitive to irradiation. We also observed unexpected differences in p53 target gene activation between the transverse and descending colon. Finally, in the liver where irradiation did not lead to caspase-3 activation, we primarily observed p21WAF1 induction as the major p53-dependent target gene response. Our findings indicate that the selectivity of p53 in transactivation following DNA damage in vivo results in unique tissue and cell type specificity, which may correlate with growth arrest or variable sensitivity to γ-irradiation.

INTRODUCTION

wtp533 protein exerts inhibitory effects toward the growth of abnormal cells and has been considered a guardian of the genome in preventing cancer development (1, 2, 3, 4) . This concept is supported by the fact that the p53 gene is the most common target for mutation in human cancer (5) , that p53 knockout mice show a high incidence of tumor development (6) , and that germ-line mutation of one p53 allele in humans gives rise to the Li-Fraumeni cancer-susceptibility syndrome (6) . wtp53 is a short-lived protein with a rapid turnover under normal unstressed conditions. The precise mechanism by which p53 is activated by cellular stress is not completely understood. Upon genotoxic insult, a rapid stabilization of the p53 protein and its activation leads to cell cycle arrest and/or apoptosis; the arrest allows cells to repair damaged DNA, whereas apoptosis removes damaged cells from the replicative pool to maintain genome integrity (1 , 7) . The biochemical function of p53 that best explains its effects is its sequence-specific transcriptional activity that transactivates target genes through binding a consensus motif in their genomic DNA sequences (8, 9, 10, 11) .

The ability of p53 to promote cell cycle arrest is well understood in terms of its ability to transactivate three critical target genes: p21WAF1; GADD45; and 14-3-3σ (12, 13, 14) . p21WAF1 protein binds to and inactivates cyclin-dependent kinases, arrests cells in G1 and prevents S-phase entry. GADD45 and 14-3-3σ appear to be involved in control of the G2-M transition (15 , 16) . A number of p53 target genes with proapoptotic activity have been identified. They fall into three groups based on their subcellular location (17) . The first group of genes encode proteins that localize to the cell membrane (e.g., CD95, KILLER/DR5, PERP). The KILLER/DR5 and CD95 (Fas/APO-1) proteins are two unique members of the tumor necrosis factor receptor superfamily that are induced by DNA damage in a p53-dependent manner and appear to be sufficient to induce apoptosis in some systems (18, 19, 20, 21) . PERP is a plasma membrane protein whose induction by doxorubicin is correlated with activation of the p53-dependent apoptotic pathway in transformed mouse embryonic fibroblasts (22) . The second group of genes encode proteins that localize to the cytoplasm, including PIDD and PIGs. PIDD can be up-regulated by γ-irradiation through a transcriptional mechanism (23) . PIGs (p53-induced genes) have been found to be involved in apoptosis by generating or responding to oxidative stress (24) . The third group of genes encode proteins that localize to the mitochondria (e.g., Bax, Noxa, Puma, p53Aip1). Bax, the best characterized mediator of p53-dependent apoptosis, translocates to the mitochondria in response to DNA damage and, in turn, induces cytochrome c release from the mitochondria (25) . Both Noxa and p53Aip1 are dependent on p53 for induction following DNA damage. Furthermore, p53Aip1 induction in response to DNA damage correlates with the phosphorylation of p53 at serine 46 and apoptosis induction (26 , 27) . Puma expression inhibits cell growth and rapidly induces apoptosis through a pathway involving cytochrome c release and activation of caspases 9 and 3 (28 , 29) . Bid was very recently found to be a p53 target and may contribute to chemosensitivity (30) .

p53+/+ and p53−/− mice have been used to study the roles of p53 itself and its previously defined targets in radiosensitivity in vivo (31, 32, 33, 34, 35, 36, 37) . p53 null-mice have been found to be resistant to apoptosis induced by γ-irradiation in the developing nervous system (35) , spleen, thymus (36) , and the small intestine (31 , 36 , 37) . Additionally, p53-null mice have been found to be resistant to the apoptosis triggered by 5-fluorouracil in small intestine (38 , 39) by 1-β-d-arabinofuranosylcytosine in sympathetic neurons (40) and by adriamycin in the thymus, spleen, and small intestine (36) . The activity of the p53 apoptotic pathway varies widely between tissues. A systematic investigation p53 target gene induction in vivo is of interest because it may lead to strategies for possible interference with expression. In addition, understanding the patterns of gene induction in vivo may help with the elucidation of pathways of cross-talk between factors affecting cell fate after irradiation.

To date, although a large number of p53 targets have been identified as candidate effectors of p53-dependent apoptosis, none of them appears to be a principal mediator of the p53 apoptotic signal. We hypothesized there may be uniqueness among p53 targets and that there may be tissue/cell type specificity in their regulation in response to a variety of stimuli that signal p53-dependent apoptosis. In addition, we hypothesized there may be coordinate regulation of apoptotic targets that may ultimately correlate with radiosensitivity. In the present studies, one representative target of p53 function in growth arrest, p21WAF1 (12) and four recently identified p53 target genes functioning in cell death/apoptosis (KILLER/DR5, Bid, Noxa, and Puma; Refs. 20 , 26 , 28, 29, 30 ) were systematically studied. We found that γ-irradiation-induced p53 transactivation leads to some apparent overlap as well as unique tissue/cell type specificity. The observed patterns may correlate with caspase-3 activation in the corresponding tissues and provide some insights into the variable sensitivity of tissues to γ-irradiation.

MATERIALS AND METHODS

Animals and γ-Irradiation.

Five- to six-week old female p53+/+ and p53−/− mice were obtained from Jackson Laboratories. Two p53+/+ mice and two p53−/− mice received total body γ-irradiation using a dose of 5 Gy, whereas an additional two p53+/+ mice and p53−/− mice were used as experimental controls with no treatment. The mice were euthanized 6 h later using an approved Institutional Animal Care and Use Committee Protocol, which followed recommendations of the Panel on Euthanasia of the American Veterinary Medical Association. Thymus, spleen, liver, duodenum, jejunum, ileum, transverse colon, and descending colon were harvested, fixed in 4% paraformaldehyde overnight at 4°C and paraffin embedded.

Probe Preparation and in Situ Hybridization.

IMAGE clones of mouse Puma and Noxa purchased from ResGen Invitrogen Corporation were prepared to generate mouse Puma and Noxa cDNA fragments. Approximately 500-bp PCR products of mouse p21WAF1 (12) mouse KILLER/DR5 (21) , mouse Bid (30) , mouse Puma, and Noxa were cloned into the Topo-TA vector (Invitrogen) with both sp6 and T7 promoters in order to make either antisense or sense RNA probes with a Dig RNA labeling kit (SP6/T7; Roche). The subcloned cDNA fragments were sequenced to confirm the authenticity of the inserts before their use to generate in situ RNA probes. In situ hybridization was performed as described previously (41) .

Immunohistochemistry.

Routine 5-μm paraffin sections were prepared. Deparaffinized sections were heated for 15 min in 0.01 m citrate buffer (pH 6.2) in a microwave oven for antigen retrieval. The sections were then immunostained using the ABC peroxidase method followed by a weak hematoxylin counterstain. In some cases, 0.5% methyl green was used as the counterstain. The primary antibodies used were those that could detect active mouse Caspase-3 (Novacastra), mouse Ki67 (Novacastra), or mouse p53 (Santa Cruz Biotechnology).

TUNEL Assay.

The TUNEL assay was performed by using the ApopTag Plus Peroxidase in Situ Apoptosis Detection Kit (Intergen, Purchase, NY) following the protocols provided by the manufacturer.

RESULTS

Variable Levels of p53-dependent Apoptotic Activity in γ-Irradiated Tissues.

The p53 tumor suppressor pathway is a pivotal mediator of genotoxic stress responses. These responses ultimately protect the organism from accumulating genetically altered and potentially cancerous cells by inducing growth arrest and/or apoptosis in damaged cells (3 , 4) . To better define the relationship between the apoptotic response to γ-irradiation and p53 status/p53 target gene activation, we systematically measured caspase-3 activity in various tissues of control and irradiated (5 Gy) wild-type or p53-null mice. As expected from previous studies that have measured DNA fragmentation, poly(ADP-ribose)polymerase cleavage, or TUNEL staining in tissues, the induction of cell death after γ-irradiation as measured by the active caspase-3 assay appears to require the presence of wtp53. wtp53-containing thymus, spleen, duodenum, jejunum, ileum, transverse colon, and descending colon all induced caspase-3 activity to differing extents after irradiation (Fig. 1)⇓ . The observed cell death induction was correlated with increased p53 protein expression after radiation, although there was no obvious correlation between the magnitude of p53 stabilization and the degree to which caspase-3 was activated (Figs. 1⇓ and 2⇓ ). p53+/+ jejunum- and ileum-activated caspase-3 in response to γ-irradiation to extremely high levels as compared with other tissues. In contrast, the level of caspase-3 activity was too weak to be detected in liver tissue sections. To confirm these two extremes of possible response (ileum/jejunum versus liver), we performed TUNEL assay and analysis of the proliferation marker ki67 in irradiated jejunum, ileum, and liver. We detected a strong signal by TUNEL assay in irradiated p53+/+ jejunum and ileum (Fig. 3A)⇓ coupled with decreased ki67 expression (Fig. 3B)⇓ . In the liver, we detected a weak signal after irradiation by TUNEL assay and a strong signal for ki67 expression. Thus, the two extremes in caspase-3 activity between liver and small bowel have been confirmed by an independent measure of cell death in vivo. In summary, p53 is required for irradiation-induced apoptosis in vivo, and the level of p53-dependent apoptosis appears to vary widely in a tissue-specific manner with a minimum apoptosis observed in the liver, and a maximum death observed in the small bowel.

Fig. 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1.

γ-Irradiation-induced cell death in vivo is p53-dependent and varies in a tissue-specific manner. Caspase-3 activity in p53+/+ or p53−/− mouse tissues. Immunohistochemistry was performed using the ABC peroxidase method by using an antibody against active caspase-3. The brown color located in cytoplasm represents the stained active caspase-3. The active caspase-3 appears in all irradiated p53+/+ tissues except liver. Images of nonirradiated p53−/− tissues (data not shown) are similar to the nonirradiated p53+/+ tissues (Duo = duodenum, Jej = jejunum, TC = transverse colon, DC = descending colon.

Fig. 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 2.

Stabilization of p53 protein expression in vivo after γ-irradiation. In situ expression of p53 protein in irradiated and nonirradiated mouse tissues. Immunohistochemistry was performed on mouse tissue sections using the ABC peroxidase method by using an antibody against p53. The stained p53 protein appears as a gray color in the tissue sections (examples indicated by arrows) with a green counterstaining. In most of tissues presented here, the level of stained p53 is to some extent elevated in irradiated sections with p53+/+ as compared with nonirradiated tissues. Images of nonirradiated p53−/− tissues (data not shown) are similar to the irradiated p53−/− tissues. Duo = duodenum, Jej = jejunum, TC = transverse colon, DC = descending colon.

Fig. 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 3.

Apoptotic death and growth arrest patterns in irradiated small bowel versus liver of wild-type and p53-null mice. A, TUNEL assay in mouse jejunum, ileum, and liver. ApopTag plus peroxidase kit was used. The apoptotic nuclei are stained brown. The brown nuclei appear only in p53+/+-irradiated jejunum and ileum and not in liver. B, immunostaining for Ki67 expression in mouse jejunum, ileum, and liver. The expressed Ki67 protein stains nuclei brown. Brown nuclei are extensively noted in unirradiated tissues, as well as irradiated p53+/+ liver but not in irradiated p53+/+ jejunum and ileum. Images of non-irradiated p53−/− tissues are similar to irradiated p53−/− tissues. Jej, jejunum.

p53-dependent p21WAF1 Induction by γ-Irradiation in Liver and Other Tissues Inversely Correlates with the Degree of p53-dependent Apoptosis in Vivo.

The role of p53 protein in both cell proliferation and apoptosis is mainly mediated through its ability to transactivate target genes. p21WAF1 (12 , 42) is a well-known mediator of p53 function in cell cycle arrest in response to DNA damage. Moreover, numerous studies have observed that p21WAF1 exerts a protective effect toward cell death and that deletion of p21WAF1 confers sensitivity to a number of apoptotic stimuli. To systemically gain insight into the radiation response in vivo and possible influence of p21WAF1 on death versus arrest responses, we examined p21WAF1 expression by in situ hybridization in tissues from irradiated or control wild-type and p53-null mice. Fig. 4⇓ and Table 1⇓ show that p21WAF1 was strongly induced by γ-irradiation in p53+/+ liver (Fig. 4A)⇓ and descending colon (Fig. 4C)⇓ and slightly in p53+/+ thymus (Fig. 4B)⇓ , spleen (Fig. 4B)⇓ , duodenum (Fig. 4C)⇓ , ileum, and transverse colon (Fig. 4A)⇓ , but there is no induction by γ-irradiation in p53−/− tissues studied here, except for a slight induction in p53−/− thymus and spleen (Fig. 4B)⇓ and no induction in p53+/+ jejunum (Fig. 4C)⇓ . p21WAF1 basal expression was notably high in p53−/− jejunum, ileum, and descending colon (Fig. 4, A and C)⇓ . This is consistent with previous observations regarding p53-independent p21WAF1 expression in colonic epithelium (42) . Interestingly, the level of p21WAF1 expression was much higher in nonirradiated p53−/− descending colon as compared with p53+/+ descending colon (Fig. 4C)⇓ . As a control, no signal was detected from tissue sections after hybridization with the sense p21WAF1 probe (data not shown). Taken together with the data shown in Fig. 1⇓ and Table 1⇓ , the strongest p21WAF1 induction after γ-irradiation occurred in tissues with the least or absent p53-dependent apoptotic activity. Thus, p21WAF1 induction in tissues in response to γ-irradiation is generally p53-dependent and varies in a tissue-specific manner, which appears to inversely correlate with the level of p53-dependent apoptotic activity occurring in the corresponding tissues.

Fig. 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 4.

p53-dependent and -independent expression of p21 in vivo; unique induction of p21 as a p53 target gene in liver following γ-irradiation. A, p21waf1 mRNA expression in mouse liver, ileum, and transverse colon. The signal appears as blue/dark purple with pink/red color counterstaining. The blue color is significantly noted in irradiated p53+/+ liver and moderately noted in irradiated p53+/+ ileum and transverse colon. The images of nonirradiated and irradiated p53−/− tissues (data not shown) are similar to the nonirradiated p53+/+ tissues. TC = transverse colon. B, p21waf1 mRNA expression in mouse thymus and spleen. The signal appears as blue/dark purple with pink/red color counterstaining. The blue color is moderately noted in irradiated p53+/+ thymus and spleen and is also detectable in irradiated p53−/− thymus and spleen but not in nonirradiated tissues. The images of nonirradiated p53−/− tissues (data not shown) are similar to the nonirradiated p53+/+ tissues. C, p21waf1 mRNA expression in mouse duodenum, jejunum, and descending colon. The signal appears as blue/dark purple with pink/red color counterstaining. The blue signal is readily noted in all tissue sections but the nonirradiated p53−/− duodenum and nonirradiated p53+/+ descending colon. Duo = duodenum, Jej = jejunum, DC = descending colon.

View this table:
  • View inline
  • View popup
Table 1

Patterns of p53 target gene expression in mouse tissues

wtp53-dependent KILLER/DR5 Induction in Response to γ-Irradiation in Thymus, Spleen, and Transverse Colon.

KILLER/DR5 was identified as a proapoptotic member of the tumor necrosis factor-related apoptosis-inducing ligand receptor family in a screen for p53 targets up-regulated in chemosensitive but not chemoresistant ovarian carcinoma cells (20) . We therefore investigated KILLER/DR5 expression by in situ hybridization using unirradiated and irradiated tissues from the wild-type and p53-null mice. We found (Fig. 5⇓ and Table 1⇓ ) that in p53−/− and p53+/+ descending colon, p53−/− and p53+/+ ileum, and p53+/+ thymus, spleen, transverse colon, and descending colon, KILLER/DR5 is slightly induced by γ-irradiation but not in other p53−/− or p53+/+ tissues examined (liver, duodenum, jejunum). KILLER/DR5 basal expression appears in all tissues but the thymus (Fig. 5A)⇓ , with a wtp53-dependent induction in duodenum (Fig. 5B)⇓ . In the thymus (Fig. 5A)⇓ , there was a greater induction of DR5 in p53+/+ tissue as compared with p53−/−. In contrast, KILLER/DR5 expression was increased by irradiation and did not correlate with wtp53 status in the ileum (Fig. 5B)⇓ and descending colon (Fig. 5A)⇓ . These results indicate that KILLER/DR5 can be expressed in a p53-dependent or -independent manner and that the p53 dependence varies in a tissue-specific manner (in situ hybridization by using sense DR5 probe was also performed, and no signal was detectable; data not shown). The mechanism of p53-independent KILLER/DR5 induction in vivo in the thymus (Fig. 5A)⇓ , duodenum (Fig. 5B)⇓ , and descending colon (Fig. 5A)⇓ remains unclear. Possibilities include a potential role for p53 family members such as p63 or p73 or pathways that are independent of the p53 family. It should be noted, however, that the major induction of KILLER/DR5 after γ-irradiation in the thymus and spleen (Fig. 5A)⇓ is p53-dependent, and in the transverse colon (Fig. 5A)⇓ , KILLER/DR5 induction by irradiation appears to occur exclusively in a p53-dependent manner.

Fig. 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 5.

Basal and p53-dependent γ-irradiation-induced KILLER/DR5 expression in vivo. A, In situ DR5 mRNA expression in mouse thymus, spleen, liver, transverse colon, and descending colon. The signal appears as blue/dark purple color with pink/red color as the counterstaining. The elevated blue color is noted in irradiated p53+/+ thymus, spleen, transverse, and descending colon and in irradiated p53−/− thymus, spleen, and descending colon as compared with nonirradiated tissues. The images of nonirradiated p53−/− tissues (data not shown) are similar to the nonirradiated p53+/+ tissues. TC = transverse colon, DC = descending colon. B, In situ DR5 mRNA expression in mouse duodenum, jejunum, and ileum. The signal appears as blue/dark purple color with pink/red color as the counterstain. There is no elevation of blue color in response to γ-irradiation. The blue signal in the duodenum appears to correlate with p53+/+ status. Duo = duodenum, Jej = jejunum, Il = ileum.

Bid Expression Depends on wtp53 after γ-Irradiation in Spleen, Thymus, and Transverse Colon.

Bid is a BH3 homology domain-containing protein that acts as a bridge in apoptotic signaling between the extrinsic death receptor pathway and the mitochondrial pathway (43) . Bid was recently identified as a p53 target gene (30) and was suggested to contribute to chemosensitivity. Thus, Bid was chosen as a target to further identify correlates between p53 target gene induction and irradiation-induced apoptosis in vivo. Fig. 6⇓ and Table 1⇓ show that among all p53-null tissues, Bid expression is detectable in irradiated jejunum and thymus. Among all p53+/+ tissues, Bid induction by γ-irradiation shows a readily detectable increase in the transverse colon (Fig. 6A)⇓ and a more moderate increase in the thymus (Fig. 6B)⇓ and spleen (Fig. 6A)⇓ . Bid basal expression, interestingly, is very strong in p53+/+ jejunum with no detectable difference between nonirradiated and irradiated jejunum (Fig. 6C)⇓ , indicating that Bid basal expression may depend on wtp53 but that induction by γ-irradiation may occur in the absence of p53 in this tissue. The signal from the sense probe was too weak to detect (data not shown). Thus, the dependence of Bid expression on wtp53 and its induction after irradiation appears tissue specific.

Fig. 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 6.

Basal and p53-dependent γ-irradiation-induced Bid expression in vivo. A, Bid mRNA expression in mouse spleen, duodenum, ileum, transverse colon, and descending colon. Increased blue color is noted in irradiated p53+/+ red pulp of spleen and in the transverse colon. The images of nonirradiated and irradiated p53−/− tissues (data not shown) are similar to the nonirradiated p53+/+ tissues. TC = transverse colon, DC = descending colon. B, Bid mRNA expression in mouse thymus. Increased blue color is noted in irradiated p53+/+ thymus with a slight increase in irradiated p53−/− thymus. The image of nonirradiated p53−/− thymus (data not shown) is similar to the nonirradiated p53+/+ thymus. C, Bid mRNA expression in mouse jejunum. Increased blue color is noted in irradiated p53−/− jejunum as compared with the nonirradiated p53−/− jejunum. There is high basal expression of Bid mRNA in the p53+/+ jejunum with no additional increase after irradiation. Jej = jejunum.

Noxa Expression Is Strongly Induced in Thymus after γ-Irradiation.

Noxa (26) appears to be a candidate mediator of p53-dependent apoptosis as its induction after γ-irradiation in mouse cells depends on wtp53. To study Noxa regulation by p53 in vivo, we performed in situ hybridization to detect Noxa mRNA expression in tissues obtained from p53+/+ or p53−/− mice with or without γ-irradiation by using the antisense and sense Noxa probes simultaneously. We found that Noxa was induced by γ-irradiation in p53-null (or p53+/+) thymus, duodenum, jejunum, and transverse colon and in p53+/+ (but not p53-null) spleen (Fig. 7⇓ and Table 1⇓ ). The induction of Noxa following γ-irradiation is very strong in p53+/+ thymus (Fig. 7B)⇓ , suggesting a possible role for Noxa induction in the cell death that occurs in the thymus. Noxa expression was found to be relatively high in unirradiated duodenum (Fig. 7B)⇓ , jejunum (Fig. 7B)⇓ , and ileum (Fig. 7A)⇓ from either p53+/+ or p53−/− animals, as compared with the remainder of the untreated tissues that were examined. Data is not shown for the nondetectable Noxa sense signal. Therefore, Noxa, as a proapoptotic target of p53, is predicted to function mainly in the thymus, followed by spleen, presumably to mediate p53-dependent apoptosis after exposure to cellular stresses or DNA-damaging exposures such as γ-radiation. The basal expression of Noxa is relatively high in the small intestine and shows no obvious correlation with p53 status, suggesting possible p53-independent function in the small bowel.

Fig. 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 7.

Tissue specificity and p53 dependence of Noxa gene induction after γ-irradiation in vivo. A, Noxa mRNA expression in mouse spleen, liver, descending colon, and ileum. Noxa mRNA expression is increased in irradiated p53+/+ red pulp of spleen but not in the irradiated p53−/− spleen. Noxa mRNA is expressed in the descending colon at higher levels in the ileum and is not additionally increased by irradiation in either of the p53+/+ or p53−/− corresponding tissues. The images of nonirradiated and irradiated p53−/− tissues (data not shown) are similar to the nonirradiated p53+/+ tissues. DC = descending colon. B, Noxa mRNA expression in mouse thymus, duodenum, jejunum, and transverse colon. Noxa mRNA expression is expressed in unirradiated thymus, increased additionally in irradiated p53+/+ thymus, and slightly increased in irradiated p53−/− thymus. Noxa mRNA expression is detectable in unirradiated duodenum and jejunum and is up-regulated to a similar extent in p53+/+ and p53−/− duodenum and jejunum, although the level of Noxa mRNA expression appears higher in irradiated jejunum versus duodenum. Noxa expression was not detectable in unirradiated transverse colon and was induced by irradiation regardless of p53 status. The images of nonirradiated p53−/− tissues (data not shown) are similar to the nonirradiated p53+/+ tissues. Duo = duodenum, Jej = jejunum, TC = transverse colon.

Dependence of Puma Expression on wtp53 in Spleen and Descending Colon and Localized Induction in White Pulp but Not Red Pulp of Spleen after γ-Irradiation.

Puma encodes a p53-up-regulated modulator of apoptosis, a member of the bcl-2 family, which may play a role in mediating p53-induced cell death through activation of mitochondrial cytochrome c release (28 , 29) . We investigated the basal expression of Puma as well as its induction after irradiation of wild-type and p53-null mice. We found no detectable induction of Puma expression by irradiation in any p53−/− tissue examined, except for duodenum and thymus (Fig. 8⇓ and Table 1⇓ ). In contrast, in p53+/+ spleen (Fig. 8B)⇓ , Puma was highly induced by irradiation in the white pulp, as compared with Noxa and Bid, the induction of which occurred in the red pulp of the spleen (Figs. 6A⇓ and 7A⇓ ). Puma was also highly induced in p53+/+ thymus (Fig. 8C)⇓ and moderately induced in p53+/+ descending colon (Fig. 8B)⇓ by γ-irradiation. In the p53+/+ jejunum (Fig. 8D)⇓ , the basal level of Puma expression was higher in p53+/+ as compared with p53-null jejunum, and there was no induction observed after irradiation. Additionally, Puma was found to be expressed throughout the ileum (Fig. 8A)⇓ at similar levels between wild-type and p53-null mice. There was no induction of Puma in the ileum after irradiation (Fig. 8A)⇓ , and no detectable sense probe signal in all tissue sections presented here (data not shown). These results indicate that the basal expression of Puma, induction of its expression in response to γ-irradiation, and dependence of its expression on wtp53 vary in a tissue-specific manner. p53-dependent induction of Puma in the splenic white pulp provides a clear example where even within a given tissue, a p53-induced target can be restricted to a compartment.

Fig. 8.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 8.

Tissue specificity and p53 dependence of Puma gene induction after γ-irradiation in vivo. A, Puma mRNA expression in mouse ileum and transverse colon. Expression is noted in ileum but not in transverse colon with no detectable difference either between nonirradiated and irradiated tissues or between p53+/+ and p53−/− ileum. The images of nonirradiated and irradiated p53−/− tissues (data not shown) and nonirradiated p53+/+ tissues (data not shown) are similar to the irradiated p53+/+ tissues (shown here). TC = transverse colon. B, Puma mRNA expression in mouse spleen and descending colon. Expression is highly increased in irradiated p53+/+ splenic white pulp and is only very slightly increased in irradiated p53+/+ descending colon. The images of nonirradiated and irradiated p53−/− tissues (data not shown) are similar to the nonirradiated p53+/+ tissues (shown here). DC = descending colon. C, Puma mRNA expression in mouse thymus and liver. Expression is elevated in irradiated thymus with high elevation in p53+/+ thymus and a slight increase in irradiated p53+/+ liver. The images of nonirradiated p53−/− tissues (data not shown) are similar to the nonirradiated p53+/+ tissues. D, Puma mRNA expression in mouse duodenum and jejunum. The purple color is observed in all sections of duodenum and jejunum but much higher in p53+/+ sections with a little irradiation response in p53−/− duodenum only. Duo = duodenum, Jej = jejunum.

DISCUSSION

A number of recently discovered p53 target genes proposed as candidate mediators of DNA damage-induced apoptosis has been examined here for their induction during cell death in vivo. Our results provide critical new insights into the complexity of the radiation response within tissues in vivo. We recognized several patterns of gene expression by in situ hybridization using probes for p53 target genes, including the cyclin-dependent kinase inhibitor p21WAF1, as well as the proapoptotic genes KILLER/DR5, Noxa, Bid, and Puma. The observed patterns include the following (see Table 1⇓ ): (a) no detectable basal expression in either wtp53-expressing or p53-null tissues but strong induction after exposure to 5 Gy γ-radiation; (b) detectable basal expression in p53+/+ and p53−/− tissue and additional induction after irradiation; (c) detectable basal expression in p53+/+ and p53−/− tissue but without additional induction of gene expression after irradiation; (d) no detectable expression in either p53+/+ or p53−/− tissue and no induction after irradiation; and (e) induction of gene expression after irradiation in a p53-dependent manner that is restricted to a particular tissue compartment. In addition to the patterns of gene expression, we found evidence that the coordinated induction of certain p53 targets (or the lack thereof) may correlate well with whether apoptosis was observed and also with the degree to which a particular tissue underwent rapid or massive cell death in vivo. Finally, our study provides detailed comparisons showing remarkable differences in the patterns of gene expression before and after radiation at progressively distal locations within the gastrointestinal tract or within compartments of a given tissue such as the spleen.

In situ hybridization was used to reveal the cellular localization and relative level of expression of specific p53 target genes in tissue sections. The information thus derived about temporal and spatial expression and induction of the genes after irradiation suggests distinct in vivo situations where certain p53 targets may mediate apoptosis. Although Northern analysis and quantitative reverse transcription-PCR can identify the presence of a specific mRNA, as well as its level of induction, they do not provide information about the localization of the signal to specific cell populations in relation to tissue morphology (41) . One of the major findings here is the specific compartmentalization of expression of Bid, Noxa, and Puma in irradiated spleen (Table 1⇓ , Figs. 6⇓ , 7⇓ , and 8⇓ ) observed by in situ hybridization. In our study, in situ hybridization was performed among many kinds of tissues with five different probes. We optimized the hybridization conditions to maximize the signal with recognizable tissue structure before each probe was actually hybridized systematically. The level of gene expression in different tissues remains comparable because the tissue-specific conditions performed here were generated from the same standard (maximal signal with recognizable tissue architecture) in each pre-in situ hybridization.

This is, to our knowledge, the first detailed systematic examination of expression of a group of p53 target genes, including those recently discovered by in situ methodology in the in vivo response to γ-irradiation. One of the remarkable findings of this study is the apparent tissue specificity with which p53 selects targets for activation. In response to γ-irradiation in wtp53-containing tissue, Noxa was mainly induced in the thymus, Puma in white pulp of the spleen, p21WAF1 in the liver, and Bid in the transverse colon. Different parts of small and large intestines also showed different patterns of target gene expression and activation. Interestingly, only KILLER/DR5 and Bid were induced in the transverse colon, and a low level of Puma induction in the wtp53-containing descending colon was observed in response to γ-irradiation. We note that the basal expression of several genes appears to depend on wtp53, and those genes are not significantly induced by γ-irradiation. Examination of the tissue death response after irradiation revealed increased caspase-3 activity in all tissues but liver from irradiated p53+/+ mice as compared with the corresponding tissues from irradiated p53−/− mice or nonirradiated control p53+/+ or p53−/− mice. In the case of liver, we believe the apparently exclusive preference for p21WAF1 activation, and not other p53 targets that could induce apoptosis, may, in part, explain the absence of detectable apoptotic death after radiation exposure. The p53 response profile and apparent lack of apoptosis in the liver does not exclude other types of toxicity such as necrotic death or inflammatory responses. The in situ hybridization results reveal remarkable variation in the selectivity of p53 for in vivo transactivation and the resulting gene expression patterns may correlate with the response to genotoxic stress.

γ-Irradiation induces a large variety of DNA lesions, including single- and double-strand breaks, base, and sugar damage (44 , 45) . The apoptotic pathway activated by γ-irradiation in proliferating cells is known to involve transcription of a variety of genes, among which the tumor suppressor gene p53 is one of the most relevant (46, 47, 48) . Upon activation, p53 transactivates its target genes to induce cell growth arrest and/or apoptosis, responses that must be finely balanced in order to protect cells with intact genomes and at the same eliminate excess or damaged cells. The requirement of subtle regulation is reflected here by the complex tissue- and cell-specific responses. Our studies further expand previous work (31 , 33 , 34 , 49 , 50) examining p53-dependent apoptosis in tissues of spleen, thymus, and gut. We previously showed (34) that KILLER/DR5 and p21WAF1 induction by γ-irradiation was p53 dependent in spleen, thymus, and small intestine and that there was some variation in the magnitude of gene induction using real-time reverse transcription-PCR-based measurements on bulk tissue mRNA. We have not only confirmed these observations but also provided extensive in situ studies on three new targets of p53 (Noxa, Puma, and Bid) along with KILLER/DR5 and p21WAF1 in spleen, thymus, and liver, and we further investigated various portions of small and large intestines. Interestingly, the response to γ-irradiation in the spleen revealed evidence for p53-dependent cell death throughout the organ but various proapoptotic (BH3-domain containing) p53 targets were up-regulated in separate compartments; Bid and Noxa were expressed in the red pulp of the spleen, whereas Puma was induced in the white pulp. The molecular basis for compartmentalized regulation of specific p53 targets within a given tissue is not understood at present. In itself the compartmentalization suggests candidate mediators of death in certain locations (because they are induced there) and also suggests that there may be unique functions of certain p53 targets in certain situations in vivo. Possible mechanisms for additional investigation for the selectivity of p53 for different targets in different tissue compartments within the spleen include (a) potential differences in p53 modification in the radiation response in different tissue compartments, and (b) potential tissue compartment-specific proteins that may positively or negatively regulate the selectivity of p53 for either particular DNA binding sequences or the transactivation of particular target genes.

In response to apoptotic signals, p53 protein is stabilized and activated, leading to transcriptional activation of multiple target genes that cause apoptosis of cells. These include death receptors, including Fas/Apo or KILLER/DR5 or proteins that are involved in mitochondria-mediated apoptosis, including Bax, Noxa, Puma, and p53Aip1. Activation of mitochondria-mediated apoptosis represents a major antitumor response of p53 (51) . Among the identified target genes of p53, Bax encodes a proapoptotic Bcl-2 family member that can activate mitochondria-mediated apoptosis (25) . However, in Bax-deficient mice, DNA damage-induced apoptosis occurs normally in thymocytes (52) . Our data that Noxa was strongly induced by γ-irradiation in p53+/+ thymus may, in part, explain why apoptosis still occurs in Bax-deficient thymus.

The small intestine represents one of the most rapidly proliferating tissues of the body, with cell division occurring approximately every 5 min in each crypt (53) . Despite its high proliferation rate, cancers rarely develop in the small intestine, suggesting that this tissue contains an efficient mechanism for regulating cell growth (54) . Our data shows that all the proapoptotic p53 target genes studied here were to, at some extent, expressed in jejunum and ileum, and we suspect they may act synergistically to contribute to the strong wtp53-dependent caspase-3 activation in jejunum and ileum after γ-irradiation. In contrast to the jejunum and ileum, there are less proapoptotic p53 targets expressed in the transverse and descending colon, which may correlate with the relatively low caspase-3 activity detected after irradiation. Liver is the only tissue studied here that did not display caspase-3 activation in the presence of wtp53 after γ-irradiation. This is in agreement with previous studies showing that liver does not undergo apoptosis after γ-irradiation (33 , 55) . However, significant p21WAF1 expression was induced in p53+/+ liver (Fig. 4)⇓ , whereas none of the other proapoptotic targets studied here was significantly up-regulated. p21WAF1 seems to play an important role in determining whether a cell should undergo apoptosis or survive with p21WAF1 expression appearing to favor growth or growth arrest over cell death (56, 57, 58, 59) . Therefore, the pattern of p53 target gene expression in liver may explain, at least in part, the inability of γ-irradiation to induce caspase-3 activation, and this correlates with the resistance of liver to radiation-induced apoptosis.

The role of p53 in radiosensitivity is complex. In some cases, expression of wtp53 is associated with an increase in the sensitivity to anticancer treatment (60, 61, 62, 63) . Although loss of p53 function can also result in increased sensitivity to anticancer treatment in other situations (55 , 64) . In the current study, all patterns of gene expression demonstrate distinct tissue/cell type specificity as well as some overlap in gene expression/induction of p53 targets, which seems to correlate well with the level of caspase-3 activation in particular tissues. Therefore, our study supports the concept that wtp53 contributes to radiosensitivity. It appears that induction of more proapoptotic target genes resulted in a stronger apoptotic response, e.g., in jejunum and ileum. In the future, additional p53 targets need to be analyzed, and in fact, it would be extremely useful to perform microarray analyses investigating global gene expression patterns in the radiation response of different tissues. In addition to the striking patterns of tissue specificity, the present studies provide a framework within which future studies can analyze p53 or proapoptotic targets of interest. The patterns of gene expression may suggest markers of tissue responsiveness to therapeutic manipulations and may provide essential clues to modulate tissue toxicity. In this regard, it will be of interest to determine whether tumors that arise from a given tissue maintain the genetically programmed p53 activation response profile as compared with the normal tissue of origin. If they do, one could envision scenarios where (transient) blockade of a proapoptotic p53 target not involved in the therapeutic response of a metastatic tumor may protect normal tissues exposed to chemotherapy or radiotherapy where the proapoptotic target gene induction contributes to toxicity. Another important direction that emerges from our studies involves additional work to understand the relationship, if any, between the observed strong DNA damage p53-mediated apoptotic response in the small bowel of mice and the observed low incidence of intestinal tumors in humans. We hypothesize that (prolonged) blockade of the p53-dependent apoptotic response to genotoxic stress in the small intestine may influence tumor susceptibility, especially in backgrounds where small intestinal tumors occur such as in min mice or individuals with familial polyposis and especially if the p53 response is activated by various endogenous or exogenous exposures. Experimentally, this may be approached through either small intestine-specific deletion of p53 or through small intestine-specific expression of potent antiapoptotic genes. In summary, the present studies provide a foundation for future studies to analyze the genetic basis, therapeutic implications, and tissue specificity of the in vivo p53-mediated stress response.

Acknowledgments

We thank Timothy F. Burns for critically reviewing the manuscript, thoughtful suggestions, and help with collecting tissue and Joanna K. Sax for reviewing the manuscript. We also thank the Morphology Core in the Center for Molecular Studies of Digestive and Liver diseases at the University of Pennsylvania for their expert assistance.

Footnotes

  • ↵1 This study was supported, in part, by NIH grants. W. S. E-D. is an Assistant Investigator of the Howard Hughes Medical Institute.

  • ↵2 To whom requests for reprints should be addressed, at Laboratory of Molecular Oncology and Cell Cycle Regulation, Howard Hughes Medical Institute, University of Pennsylvania School of Medicine, 415 Curie Boulevard, CRB 437A, Philadelphia, PA 19104. Phone: (215) 898-9015; Fax: (215) 573-9139; E-mail: wafik{at}mail.med.upenn.edu

  • ↵3 The abbreviations used are: wtp53, wild-type p53; ABC, avidin-biotin complex; TUNEL, terminal deoxynucleotidyl transferase-mediated nick end labeling.

  • Received August 2, 2002.
  • Accepted November 6, 2002.
  • ©2002 American Association for Cancer Research.

References

  1. ↵
    Gottlieb T. M., Oren M. p53 in growth control and neoplasia. Biochim. Biophys. Acta, 1287: 77-102, 1996.
    OpenUrlPubMed
  2. ↵
    Levine A. J. p53, the cellular gatekeeper for growth and division. Cell, 88: 323-331, 1997.
    OpenUrlCrossRefPubMed
  3. ↵
    Prives C., Hall P. A. The p53 pathway. J. Pathol., 187: 112-126, 1999.
    OpenUrlCrossRefPubMed
  4. ↵
    Tlsty T. D. Functions of p53 suppress critical consequences of damage and repair in the initiation of cancers. Cancer Cell, : 2-4, 2002.
  5. ↵
    Hollstein M., Sidransky D., Vogelstein B., Harris C. C. p53 mutations in human cancers. Science (Wash. DC), 253: 49-53, 1991.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Donehower L. A. The p53-deficient mouse: a model for basic and applied cancer studies. Semin. Cancer Biol., 7: 269-278, 1996.
    OpenUrlCrossRefPubMed
  7. ↵
    Ko L. J., Prives C. p53: puzzle and paradigm. Genes Dev., 10: 1054-1072, 1996.
    OpenUrlFREE Full Text
  8. ↵
    El-Deiry W. S., Kern S. E., Pietenpol J. A., Kinzler K. W., Volglstein B. Definition of a consensus binding site for p53. Nat. Genet., : 45-49, 1992.
  9. ↵
    Bourdon J. C., Deguin-Chambon V., Lelong J. C., Dessen P., May P., Debuire B., May E. Further characterisation of the p53 responsive element identification of new candidate genes for transactivation by p53. Oncogene, 14: 85-94, 1997.
    OpenUrlCrossRefPubMed
  10. ↵
    El-Deiry W. S. Regulation of p53 downstream genes. Semin. Cancer Biol., 8: 345-357, 1998.
    OpenUrlCrossRefPubMed
  11. ↵
    Funk W. D., Pak D. T., Karas R. H., Wright W. E., Shay J. W. A transcriptionally active DNA-binding site for human p53 protein complexes. Mol. Cell. Biol., 12: 2866-2871, 1992.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    El-Deiry W. S., Tokino T., Velculescu V. E., Levy D. B., Parsons R., Trent J. M., Lin D., Mercer W. E., Kinzler K. W., Volgelstein B. wAF1, a potential mediator of p3 tumor suppression. Cell, 75: 817-825, 1993.
    OpenUrlCrossRefPubMed
  13. ↵
    Kastan M. B., Zhan Q., El-Deiry W. S., Carrier F., Jacks T., Walsh W. V., Plunkett B. S., Vogelstein B., Fornace A. J., Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71: 587-597, 1992.
    OpenUrlCrossRefPubMed
  14. ↵
    Hermeking H., Lengauer C., Polyak K., He T. C., Zhang L., Thiagalingam S., Kinzler K. W., Vogelstein B. 14-3-3σ is a p53-regulated inhibitor of G2/M progression. Mol. Cell, 1: 3-11, 1997.
    OpenUrlCrossRefPubMed
  15. ↵
    Wang X. W., Zhan Q., Coursen J. D., Khan M. A., Kontny H. U., Yu L., Hollander M. C., O’Connor P. M., Fornace A. J., Jr., Harris C. C. GADD45 induction of a G2-M cell cycle checkpoint. Proc. Natl. Acad. Sci. USA, 96: 3706-3711, 1999.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    Chan T. A., Hwang P. M., Hermeking H., Kinzler K. W., Vogelstein B. Cooperative effects of genes controlling the G2-M checkpoint. Genes Dev., 14: 1584-1588, 2000.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    Benchimol S. p53-dependent pathways of apoptosis. Cell Death Differ., 8: 1049-1051, 2001.
    OpenUrlCrossRefPubMed
  18. ↵
    Owen-Schaub L. B., Angelo L. S., Radinsky R., Ware C. F., Gesner T. G., Bartos D. P. Soluble Fas/APO-1 in tumor cells: a potential regulator of apoptosis?. Cancer Lett., 94: 1-8, 1995.
    OpenUrlCrossRefPubMed
  19. ↵
    Muller M., Wilder S., Bannasch D., Israeli D., Lehlbach K., Li-Weber M., Friedman S. L., Galle P. R., Stremmel W., Oren M., Krammer P. H. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J. Exp. Med., 188: 2033-2045, 1998.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    Wu G. S., Burns T. F., Mcdonald E. R., III, Jiang W., Meng R., Krantz I. D., Kao G., Gan D. D., Zhou J. Y., Muschel R., Hamilton S. R., Spinner N. B., Markowitz S., Wu G., El-Deiry W. S. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat. Genet., 17: 141-143, 1997.
    OpenUrlCrossRefPubMed
  21. ↵
    Wu G. S., Burns T. F., McDonald E. R., III, Meng R. D., Kao G., Muschel R., Yen T., El-Deiry W. S. Induction of the TRAIL receptor KILLER/DR5 in p53-dependent apoptosis but not growth arrest. Oncogene, 18: 6411-6418, 1999.
    OpenUrlCrossRefPubMed
  22. ↵
    Attardi L. D., Reczek E. E., Cosmas C., Demicco E. G., McCurrach M. E., Lowe S. W., Jacks T. PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev., 14: 704-718, 2000.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    Lin Y., Ma W., Benchimol S. Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis. Nat. Genet., 26: 122-127, 2000.
    OpenUrlCrossRefPubMed
  24. ↵
    Polyak K., Xia Y., Zweier J. L., Kinzler K. W., Vogelstein B. A model for p53-induced apoptosis. Nature (Lond.), 389: 300-305, 1997.
    OpenUrlCrossRefPubMed
  25. ↵
    Miyashita T., Kitada S., Krajewski S., Horne W. A., Delia D., Reed J. C. Overexpression of the Bcl-2 protein increases the half-life of p21Bax. J. Biol. Chem., 270: 26049-26052, 1995.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    Oda E., Ohki R., Murasawa H., Nemoto J., Shibue T., Yamashita T., Tokino T., Taniguchi T., Tanaka N. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science (Wash. DC), 288: 1053-1058, 2000.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    Oda K., Arakawa H., Tanaka T., Matsuda K., Tanikawa C., Mori T., Nishimori H., Tamai K., Tokino T., Nakamura Y., Taya Y. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell, 102: 849-862, 2000.
    OpenUrlCrossRefPubMed
  28. ↵
    Yu J., Zhang L., Hwang P. M., Kinzler K. W., Vogelstein B. PUMA induces the rapid apoptosis of colorectal cancer cells. Mol. Cell, 7: 673-682, 2001.
    OpenUrlCrossRefPubMed
  29. ↵
    Nakano K., Vousden K. H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell, 7: 683-694, 2001.
    OpenUrlCrossRefPubMed
  30. ↵
    Sax J. K., Fei P., Murphy M. E., Bernhardt E., Korsmeyer S. J., El-Deiry W. S. Bid transcriptional regulation by p53 contributes to chemosensitivity. Nat. Cell Biol., 4: 842-849, 2002.
    OpenUrlCrossRefPubMed
  31. ↵
    Merritt A. J., Potten C. S., Kemp C. J., Hickman J. A., Balmain A., Lane D. P., Hall P. A. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res., 54: 614-617, 1994.
    OpenUrlAbstract/FREE Full Text
  32. ↵
    MacCallum D. E., Hupp T. R., Midgley C. A., Stuart D., Campbell S. J., Harper A., Walsh F. S., Wright E. G., Balmain A., Lane D. P., Hall P. A. The p53 response to ionising radiation in adult and developing murine tissues. Oncogene, 13: 2575-2587, 1996.
    OpenUrlPubMed
  33. ↵
    Bouvard V., Zaitchouk T., Vacher M., Duthu A., Canivet M., Choisy-Rossi C., Nieruchalski M., May E. Tissue and cell-specific expression of the p53-target genes: bax, fas, mdm2 and waf1/p21, before and following ionising irradiation in mice. Oncogene, 19: 649-660, 2000.
    OpenUrlCrossRefPubMed
  34. ↵
    Burns T. F., Bernhard E. J., El-Deiry W. S. Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo. Oncogene, 20: 4601-4612, 2001.
    OpenUrlCrossRefPubMed
  35. ↵
    Herzog K. H., Chong M. J., Kapsetaki M., Morgan J. I., McKinnon P. J. Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system. Science (Wash. DC), 280: 1089-1091, 1998.
    OpenUrlAbstract/FREE Full Text
  36. ↵
    Komarova E. A., Chernov M. V., Franks R., Wang K., Armin G., Zelnick C. R., Chin D. M., Bacus S. S., Stark G. R., Gudkov A. V. Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo.. EMBO J., 16: 1391-1400, 1997.
    OpenUrlAbstract
  37. ↵
    Merritt A. J., Allen T. D., Potten C. S., Hickman J. A. Apoptosis in small intestinal epithelial from p53-null mice: evidence for a delayed, p53-independent G2-M-associated cell death after γ-irradiation. Oncogene, 14: 2759-2766, 1997.
    OpenUrlCrossRefPubMed
  38. ↵
    Pritchard D. M., Potten C. S., Hickman J. A. The relationships between p53-dependent apoptosis, inhibition of proliferation, and 5-fluorouracil-induced histopathology in murine intestinal epithelia. Cancer Res., 58: 5453-5465, 1998.
    OpenUrlAbstract/FREE Full Text
  39. ↵
    Pritchard D. M., Jackman A., Potten C. S., Hickman J. A. Chemically-induced apoptosis: p21 and p53 as determinants of enterotoxin activity. Toxicol. Lett., 102–103: 19-27, 1998.
  40. ↵
    Anderson C. N., Tolkovsky A. M. A role for MAPK/ERK in sympathetic neuron survival: protection against a p53-dependent, JNK-independent induction of apoptosis by cytosine arabinoside. J. Neurosci., 19: 664-673, 1999.
    OpenUrlAbstract/FREE Full Text
  41. ↵
    Kadol S., Juang J., and Wu T. C. In situ hybridization in cancer and normal tissue. Totowa, NJ: Humana Press, in press, 2002.
  42. ↵
    El-Deiry W. S., Tokino T., Waldman T., Oliner J. D., Velculescu V. E., Burrell M., Hill D. E., Healy E., Rees J. L., Hamilton S. R., et al Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res., 55: 2910-2919, 1995.
    OpenUrlAbstract/FREE Full Text
  43. ↵
    Li H., Zhu H., Xu C. J., Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell, 94: 491-501, 1998.
    OpenUrlCrossRefPubMed
  44. ↵
    Hutchinson F. Chemical changes induced in DNA by ionizing radiation. Prog. Nucleic Acid Res. Mol. Biol., 32: 115-154, 1985.
    OpenUrlCrossRefPubMed
  45. ↵
    Ward J. F. DNA damage produced by ionizing radiation in mammalian cells: identities, mechanisms of formation, and reparability. Prog. Nucleic Acid Res. Mol. Biol., 35: 95-125, 1988.
    OpenUrlCrossRefPubMed
  46. ↵
    Kuerbitz S. J., Plunkett B. S., Walsh W. V., Kastan M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA, 89: 7491-7495, 1992.
    OpenUrlAbstract/FREE Full Text
  47. ↵
    Hwang A., Muschel R. J. Radiation and the G2 phase of the cell cycle. Radiat. Res., 150: S52-S59, 1998.
    OpenUrlCrossRefPubMed
  48. ↵
    Kondo S. Apoptotic repair of genotoxic tissue damage and the role of p53 gene. Mutat. Res., 402: 311-319, 1998.
    OpenUrlPubMed
  49. ↵
    Midgley C. A., Owens B., Briscoe C. V., Thomas D. B., Lane D. P., Hall P. A. Coupling between γ irradiation, p53 induction and the apoptotic response depends upon cell type in vivo. J. Cell Sci., 108(Pt 5): 1843-1848, 1995.
    OpenUrlAbstract/FREE Full Text
  50. ↵
    Arai T., Kida Y., Harmon B. V., Gobe G. C. Comparative alterations in p53 expression and apoptosis in the irradiated rat small and large intestine. Br. J. Cancer, 74: 406-412, 1996.
    OpenUrlPubMed
  51. ↵
    Soengas M. S., Alarcon R. M., Yoshida H., Giaccia A. J., Hakem R., Mak T. W., Lowe S. W. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science (Wash. DC), 284: 156-159, 1999.
    OpenUrlAbstract/FREE Full Text
  52. ↵
    Knudson C. M., Tung K. S., Tourtellotte W. G., Brown G. A., Korsmeyer S. J. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science (Wash. DC), 270: 96-99, 1995.
    OpenUrlAbstract/FREE Full Text
  53. ↵
    Potten C. S., Kellett M., Rew D. A., Roberts S. A. Proliferation in human gastrointestinal epithelium using bromodeoxyuridine in vivo: data for different sites, proximity to a tumour, and polyposis coli. Gut, 33: 524-529, 1992.
    OpenUrlAbstract/FREE Full Text
  54. ↵
    Merritt A. J., Potten C. S., Watson A. J., Loh D. Y., Nakayama K., Hickman J. A. Differential expression of bcl-2 in intestinal epithelia. Correlation with attenuation of apoptosis in colonic crypts and the incidence of colonic neoplasia. J. Cell Sci., 108(Pt. 6): 2261-2271, 1995.
    OpenUrlAbstract/FREE Full Text
  55. ↵
    Shewach D. S., Lawrence T. S. Radiosensitization of human solid tumor cell lines with gemcitabine. Semin. Oncol., 23: 65-71, 1996.
    OpenUrl
  56. ↵
    Oren M., Prives C. p53: upstream, downstream, and off stream. Review of the 8th p53 workshop (Dundee, July 5–9, 1996). Biochim. Biophys. Acta., 1288: R13-R19, 1996.
    OpenUrlPubMed
  57. ↵
    Polyak K., Waldman T., He T. C., Kinzler K. W., Vogelstein B. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev., 10: 1945-1952, 1996.
    OpenUrlAbstract/FREE Full Text
  58. ↵
    Bissonnette N., Hunting D. J. p21-induced cycle arrest in G1 protects cells from apoptosis induced by UV-irradiation or RNA polymerase II blockage. Oncogene, 16: 3461-3469, 1998.
    OpenUrlCrossRefPubMed
  59. ↵
    MacLachlan T. K., Takimoto R., El-Deiry W. S. BRCA1 directs a selective p53-dependent transcriptional response towards growth arrest and DNA repair targets. Mol. Cell. Biol., 22: 4280-4292, 2002.
    OpenUrlAbstract/FREE Full Text
  60. ↵
    Lowe S. W., Schmitt E. M., Smith S. W., Osborne B. A., Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.), 362: 847-849, 1993.
    OpenUrlCrossRefPubMed
  61. ↵
    McCurrach M. E., Connor T. M., Knudson C. M., Korsmeyer S. J., Lowe S. W. bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc. Natl. Acad. Sci. USA, 94: 2345-2349, 1997.
    OpenUrlAbstract/FREE Full Text
  62. ↵
    Alsner J., Sorensen S. B., Overgaard J. TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck. Radiother. Oncol., 59: 179-185, 2001.
    OpenUrlCrossRefPubMed
  63. ↵
    Mohiuddin M., Chendil D., Dey S., Alcock R. A., Regine W., Ahmed M. M. Influence of p53 status on radiation and 5-fluorouracil synergy in pancreatic cancer cells. Anticancer Res., 22: 825-830, 2002.
    OpenUrlPubMed
  64. ↵
    Smith M. L., Fornace A. J., Jr. Genomic instability and the role of p53 mutations in cancer cells. Curr. Opin. Oncol., 7: 69-75, 1995.
    OpenUrlPubMed
PreviousNext
Back to top
Cancer Research: 62 (24)
December 2002
Volume 62, Issue 24
  • Table of Contents

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Tissue-specific Induction of p53 Targets in Vivo
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Tissue-specific Induction of p53 Targets in Vivo
Peiwen Fei, Eric J. Bernhard and Wafik S. El-Deiry
Cancer Res December 15 2002 (62) (24) 7316-7327;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Tissue-specific Induction of p53 Targets in Vivo
Peiwen Fei, Eric J. Bernhard and Wafik S. El-Deiry
Cancer Res December 15 2002 (62) (24) 7316-7327;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • FUS/ERG Gene Fusions in Ewing’s Tumors
  • The Impact of Microsatellite Instability on the Molecular Phenotype of Colorectal Tumors
  • Transcription Factor c-Jun Activation Represses mdr-1 Gene Expression
Show more Molecular Biology and Genetics
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement